Related references
Note: Only part of the references are listed.Infections with Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae Changing Epidemiology and Drug Treatment Choices
Johann D. D. Pitout
DRUGS (2010)
The DiversiLab system versus pulsed-field gel electrophoresis: Characterisation of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae
Alma Brolund et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2010)
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains
Olivier Clermont et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
The first major extended-spectrum β-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15
Birgitta Lytsy et al.
APMIS (2008)
Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Jesus Rodriguez-Bano et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Breakpoints for intravenously used cephalosporins in Enterobacteriaceae - EUCAST and CLSI breakpoints
G. Kahlmeter
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline
J. Garau
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam
L. R. Peterson
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern
Johann D. D. Pitout et al.
LANCET INFECTIOUS DISEASES (2008)
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Marie-Helene Nicolas-Chanoine et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006
Hong Fang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection
Raf De Jongh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Characterization of CTX-M and SHV extended-spectrum β-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia
Ahlem Jouini et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Cefepime pharmacodynamics in patients with extended spectrum β-lactamase (ESBL) and non-ESBL infections
Su Young Lee et al.
JOURNAL OF INFECTION (2007)
Nosocomial outbreak of CTX-M-15-producing E-coli in Norway
Umaer Naseer et al.
APMIS (2007)
CTX-M: changing the face of ESBLs in Europe
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway
Stale Tofteland et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Activity of temocillin against prevalent ESBL- and AmpC-producing enterobacteriaceae from south-east england
DM Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Activity of mecillinam against ESBL producers in vitro
K Thomas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase
E Elliott et al.
CLINICAL INFECTIOUS DISEASES (2006)
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
JDD Pitout et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Molecular epidemiological analysis of Escherichia coli isolates producing extended-spectrum β-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden
H Fang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Genetic methods for detection of antimicrobial resistance
A Sundsfjord et al.
APMIS (2004)
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases:: Implications for the clinical microbiology laboratory
DL Paterson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
